These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 6891821

  • 21. Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid.
    Bishnoi M, Chopra K, Kulkarni SK.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb 15; 32(2):451-61. PubMed ID: 17988775
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. MK-771 antagonizes the enhanced response to apomorphine in rats treated chronically with haloperidol - implications for tardive dyskinesia.
    Yarbrough GG, Faison EP, Antolik EK.
    Neurosci Lett; 1982 Dec 31; 34(3):321-3. PubMed ID: 6819493
    [Abstract] [Full Text] [Related]

  • 24. Neuroleptic-induced acute dyskinesias in rhesus monkeys.
    Porsolt RD, Jalfre M.
    Psychopharmacology (Berl); 1981 Dec 31; 75(1):16-21. PubMed ID: 6117919
    [Abstract] [Full Text] [Related]

  • 25. Oral dyskinesias and histopathological alterations in substantia nigra after long-term haloperidol treatment of old rats.
    Andreassen OA, Ferrante RJ, Aamo TO, Beal MF, Jørgensen HA.
    Neuroscience; 2003 Dec 31; 122(3):717-25. PubMed ID: 14622915
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Spontaneous and tardive dyskinesias: clinical and laboratory studies.
    Casey DE.
    J Clin Psychiatry; 1985 Apr 31; 46(4 Pt 2):42-7. PubMed ID: 2858480
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Iron pigment in the brain of a man with tardive dyskinesia.
    Campbell WG, Raskind MA, Gordon T, Shaw CM.
    Am J Psychiatry; 1985 Mar 31; 142(3):364-5. PubMed ID: 3970282
    [Abstract] [Full Text] [Related]

  • 35. Spontaneous orofacial dyskinesias in a captive cynomolgus monkey: implications for tardive dyskinesia.
    Rupniak NM, Tye SJ, Steventon MJ, Boyce S, Iversen SD.
    Mov Disord; 1990 Mar 31; 5(4):314-8. PubMed ID: 2259355
    [Abstract] [Full Text] [Related]

  • 36. High fat diet increases the incidence of orofacial dyskinesia and oxidative stress in specific brain regions of rats.
    Fachinetto R, Burger ME, Wagner C, Wondracek DC, Brito VB, Nogueira CW, Ferreira J, Rocha JB.
    Pharmacol Biochem Behav; 2005 Jul 31; 81(3):585-92. PubMed ID: 15936064
    [Abstract] [Full Text] [Related]

  • 37. Expected incidence of tardive dyskinesia associated with atypical antipsychotics.
    Glazer WM.
    J Clin Psychiatry; 2000 Jul 31; 61 Suppl 4():21-6. PubMed ID: 10739327
    [Abstract] [Full Text] [Related]

  • 38. Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.
    Correll CU, Leucht S, Kane JM.
    Am J Psychiatry; 2004 Mar 31; 161(3):414-25. PubMed ID: 14992963
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.